Selective JAK1 inhibitors for the treatment of inflammatory bowel disease
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference132 articles.
1. Randomized controlled trial substudy of cell-specific mechanisms of Janus kinase 1 inhibition with upadacitinib in the Crohn’s disease intestinal mucosa: Analysis from the CELEST study;Aguilar;Inflammatory Bowel Diseases,2021
2. Jakinibs of all trades: Inhibiting cytokine signaling in immune-mediated pathologies;Alexander;Pharmaceuticals (Basel),2021
3. The risk of infections associated with JAK inhibitors in rheumatoid arthritis: A systematic review and network meta-analysis;Alves;Journal of Clinical Rheumatology,2022
4. A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo;Bai;Cancer Cell,2019
5. JAK-STAT signaling as a target for inflammatory and autoimmune diseases: Current and future prospects;Banerjee;Drugs,2017
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. JAK/STAT signaling promotes the emergence of unique cell states in ulcerative colitis;2024-01-24
2. Emerging strategy towards mucosal healing in inflammatory bowel disease: what the future holds?;Frontiers in Immunology;2023-12-14
3. Kinase Signaling in Colitis-Associated Colon Cancer and Inflammatory Bowel Disease;Biomolecules;2023-11-06
4. Precisely Inhibiting Excessive Intestinal Epithelial Cell Apoptosis to Efficiently Treat Inflammatory Bowel Disease with Oral Pifithrin‐α Embedded Nanomedicine (OPEN);Advanced Materials;2023-10-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2023 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3